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Abstract
Introduction: Behavioural and psychological symptoms of dementia (BPS) include depressive symptoms, anxiety,
apathy, sleep problems, irritability, psychosis, wandering, elation and agitation, and are common in the non-
demented and demented population.
Methods: We have undertaken a systematic review of reviews to give a broad overview of the prevalence, course,
biological and psychosocial associations, care and outcomes of BPS in the older or demented population, and
highlight limitations and gaps in existing research. Embase and Medline were searched for systematic reviews
using search terms for BPS, dementia and ageing.
Results: Thirty-six reviews were identified. Most investigated the prevalence or course of symptoms, while few
reviewed the effects of BPS on outcomes and care. BPS were found to occur in non-demented, cognitively
impaired and demented people, but reported estimates vary widely. Biological factors associated with BPS in
dementia include genetic factors, homocysteine levels and vascular changes. Psychosocial factors increase risk of
BPS; however, across studies and between symptoms findings are inconsistent. BPS have been associated with
burden of care, caregiver’s general health and caregiver depression scores, but findings are limited regarding
institutionalisation, quality of life and disease outcome.
Conclusions: Limitations of reviews include a lack of high quality reviews, particularly of BPS other than
depression. Limitations of original studies include heterogeneity in study design particularly related to
measurement of BPS, level of cognitive impairment, population characteristics and participant recruitment. It is our
recommendation that more high quality reviews, including all BPS, and longitudinal studies with larger sample
sizes that use frequently cited instruments to measure BPS are undertaken. A better understanding of the risk
factors and course of BPS will inform prevention, treatment and management and possibly improve quality of life
for the patients and their carers.
Introduction
Behavioural and psychological symptoms (BPS) include
depressive symptoms, anxiety, apathy, sleep problems,
irritability, psychosis, wandering, elation and agitation.
They are common in people with dementia, but are not
restricted to this group [1]. BPS have public policy
implications as they impact upon quality of life of older
people and their carers, and influence prescribing and
use of services [2,3].
Systematic reviews are an important tool for summar-
ising the available evidence regarding a specific topic,
permitting policy decisions to be based on representative
literature. They allow researchers to focus on areas
where information is most lacking, and allow more reli-
able interpretation of research findings. A review of
reviews, therefore, serves two important purposes: first,
summarising the evidence base on a subject beyond the
scope of a single review, and second, highlighting areas
where the literature is inadequate and where additional
reviews are required. While the prevalence, course,
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biological and psychosocial associations, care and out-
comes of BPS have been the subject of systematic
reviews, the findings from these different reviews have
not been brought together in this way. Given the broad
research focus on BPS, including underlying causes,
association with dementia risk, and impact on care, and
the large number of studies published in this area, any
single systematic review of the primary literature can
only explore a narrow range of objectives.
This paper presents a systematic ‘review of reviews’ of
the literature on BPS in older people. Combining current
knowledge across the multiple domains of BPS research
provides a broad overview of what is known and identi-
fies gaps where reviews have not been conducted [4].
Bringing together the conclusions of the reviews, we pro-
vide recommendations for future research and highlight
areas where the evidence base with respect to BPS in the
older population should be strengthened. In addition, we
discuss the recommendations for future research made
by the reviews.
Materials and methods
Scope of review
BPS are related to cognitive impairment and dementia.
So-called “behavioural and psychological symptoms of
dementia”, BPSD, are commonly studied within this sub-
population, but BPS can also occur in older people with-
out significant cognitive impairment. Traditionally these
are considered as phenomena distinct to BPSD; however,
BPS in a cognitively healthy older person may indicate
early dementia, and certain BPS, for example, depression,
may be risk factors for dementia. Continuities in BPS are
seen ‘pre’ and ‘post’ diagnosis, and common biological
and psychosocial risk factors for BPS may exist among
the cognitively healthy and cognitively impaired older
populations. For this reason the scope of our review
includes studies of BPS in the older population with or
without cognitive impairment or dementia. We included
reviews of the prevalence, the causes and consequences
of BPS.
Owing to the breadth of literature and the specialist
treatment required to review certain kinds of study, there
are some limitations to the scope of this review. We did
not include reviews that focused on pharmacological or
non-pharmacological treatment of symptoms. Depression
is a heterogeneous disorder ranging from mild symptoms
to major depressive disorder. Depression is common in
the older population with dementia and can be studied in
the context of other BPS, but is also seen in the older
population without dementia (Figure 1). Depression in
the older population without dementia has been studied
widely since it was first described in 1896 [5,6]. The term
BPSD was introduced by the International Psychogeria-
tric Association in 1996 [7]. Although they have been
identified since the earliest descriptions of dementia,
research only moved to BPSD in the 1980s with the
development of instruments to measure BPSD [8,9].
Depression as a BPSD and depression in the older popu-
lation without dementia have largely been separate
research areas. Here, we focused on depressive symptoms
below the threshold for depressive disorder. We excluded
reviews that studied only major or clinical depression
and included reviews that studied both major depression
and minor depression, depressive symptoms or minor
depression only or depressive symptoms in the context of
other BPS.
Search methods
Embase and Medline were searched for potentially rele-
vant articles published before 29 March 2012. Search
terms included Emtree terms and text searches for each
individual BPS and BPS in general (see Additional file 1),
and Dementia (Emtree) or Aged (Emtree). Additional
articles were identified from reference lists of included
studies and relevant narrative reviews.
Data collection
All systematic reviews written in English of one or more
BPS in the older non-demented or demented population
were included. A systematic review was defined as used by
the Cochrane Collaboration and the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) Statement: “A review of a clearly formulated
question that uses systematic and explicit methods to
identify, select, and critically appraise relevant research,
and to collect and analyse data from the studies that are
included in the review. Statistical methods (meta-analysis)
may or may not be used to analyse and summarise the
results of the included studies” [10]. Specific symptoms
included depressive symptoms (including sadness, tearful-
ness, being unhappy, depressed feeling, suicidal feelings),
anxiety (including feelings and physical signs of anxiety,
worrying, being frightened), apathy (including listlessness,
loss of interest, slowing), sleep problems (includes reduced
sleep, increased sleep, change in sleep, tiredness), irritabil-
ity (including being irritable or angry, verbal and physical
aggression), psychosis (including delusion and hallucina-
tion), wandering (including wandering away, getting lost,
aimless wandering), elation (including euphoria, inap-
propriate laughing) and non-aggressive agitation (includ-
ing restlessness, repetitive behaviour).
RvdL selected articles through a multi-step screening
process first based upon the assessment of the title and
the abstract, followed by assessment of the article content.
Information from each potential article was extracted by
RvdL using a standardised form, recording: the BPS inves-
tigated, population, date of publication and literature
search, number of studies reviewed and if a meta-analysis
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was performed. Reviews were divided by the following
themes: prevalence, progression, course, biological associa-
tions, risk factors, care, quality of life and disease outcome.
Results were summarised using the abstract. A list of
recommendations for future research (for example, “future
research should”, “we recommend”, “is needed”) and lim-
itations of the original studies and review as reported by
the reviews in their discussion section was generated.
Figure 1 Populations and BPS that were the focus of the reviews.
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The quality of the included reviews was assessed using
AMSTAR, a validated measurement tool (Shea et al.
2007, Ottawa, Ontario, Canada) to assess the methodo-
logical quality of systematic reviews [11,12].
Results
Number of studies
Separate searches of each BPS resulted in 266 reviews
for depressive symptoms (N = 156 in dementia), 110 for
anxiety (N = 74 in dementia), 8 for apathy (N = 7 in
dementia), 82 for sleep problems (N = 45 in dementia),
30 for irritability (N = 24 in dementia), 42 for psychosis
(N = 33 in dementia), 3 for wandering (N = 3 in demen-
tia), 3 for elation (N = 3 in dementia), 15 for agitation
(N = 14 in dementia) and 29 for BPS (N = 28 in demen-
tia). Altogether, 399 reviews were found. Of these,
28 reviews were included. The others were excluded
because BPS were not the main focus of the paper,
instead they studied treatment or non-pharmacological
interventions, did not focus on elderly or dementia
populations, were not performed systematically or did
not meet any other inclusion criteria. Seven reviews
were excluded because they only studied major depres-
sion [13-19]. Reference searches of the included sys-
tematic reviews and relevant narrative reviews identified
nine additional reviews. Therefore, in total 36 reviews
were included.
Characteristics and focus of included reviews
Tables 1 and 2 show the characteristics of the reviews
included. Most (N = 13) [20-32] investigated the prevalence
or co-occurrence of symptoms. Eleven [21,27,30,33-40]
reviewed the longitudinal course of BPS or its associations
with incident dementia. Possible underlying biological
factors were examined in nine reviews [41-49], as were psy-
chosocial risk factors [20,24,26,27,30,31,49,50]. Only two
reviews [51,52] focused on the associations between BPS
and care outcomes, one [53] on the effects on quality of life
and four [30,32,54,55] on disease outcomes.
Figure 1 shows the populations and BPS that were the
focus of the different reviews. As shown, most reviews
focused on depression in the older population, not spe-
cifically excluding those with dementia (N = 11)
[20,29-31,35,43,44,46,48,50,56], or depression and sev-
eral other BPS in dementia (N = 6) [21,22,24,26,42,52].
Of the studies focusing on depressive symptoms or
other BPS in the older population, it was often unclear
if those with dementia were included, with only few spe-
cifically including only studies of “healthy” or “normal”
elderly [38,39] or reporting which original studies
excluded those with dementia or cognitive impairment
[28,35,43,57]. Overall, 12 reviews [20,28-32,41,45,48-50]
included studies of the entire older population (> 50
years), 3 [35,43,44] of the older population but with
some studies excluding those with dementia or cognitive
impairment, 1 [23] of patients in long-term care,
3 [40,46,47] of an adult population including older aged
adults, 2 [38,39] that only included ‘healthy’ adults, and
3 included case control studies comparing those with
dementia to normal controls [33,36,37]. In addition, 3
[21,22,24] studied cognitively impaired populations and
10 [25-27,34,42,51-55] people with dementia. Nine
reviews included a wide battery of BPS [21-24,42,51-54]
and a further three [25,26,49] focused on a combination
of two or more symptoms. Of those studying a single
symptom, depressive symptoms were most widely
reviewed (N = 18) [20,28-31,33-37,41,43-48,50]. Sleep
problems (N = 3) [38-40], psychosis (N = 2) [27,55] and
anxiety (N = 1) [32] were the subject of few reviews.
Details of the characteristics and recruitment of the
population of the original studies included in the
reviews were often not reported.
Quality
The quality assessment for each included review is
shown in Table 3. Generally, review quality was low,
with only 7 of the reviews scoring positive on 5 of the
11 components and meeting the criteria for moderate
scientific quality (5 to 8 points). All other reviews scored
less than five points.
Narrative description by theme
Prevalence of BPS
Two reviews [21,22] of BPS in populations with mild
cognitive impairment (MCI) reported an overall symp-
tom prevalence ranging from 35 to 75% and 35 to 85%.
Depressive symptoms, anxiety and irritability were the
most commonly observed symptoms, followed by apathy
and agitation. Hospital-based samples of MCI cases
reported a higher mean prevalence of any BPS than
population-based studies [21]. In people with dementia
in long term care the prevalence of one or more BPS
was 78% [23]. The mean reported prevalence of psycho-
sis in dementia was 41% [27].
Reviews of the prevalence of BPS in the older popula-
tion without dementia were available only for depres-
sion. The prevalence of depressive disorders in the older
population without dementia has been estimated to be
17.1% (95% CI 9.7 to 26.1), in a meta-analysis of moder-
ate scientific quality [28]. Other studies reported a high
variability in the prevalence reported in included studies
ranging from 14 to 82% [23], 14 to 16% [20], 0 to 35%
[58] and 7 to 49% [31]. A lower prevalence has been
reported in community settings than in primary care
and long term care settings [30].
Most reviews found considerable variability in
reported prevalence, possibly due to heterogeneity in
methodology, thereby limiting the ability to compare
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Table 1 Characteristics of included reviews and summary of findings - older population with dementia or cognitive impairment
First
author
Search
date
BPS Popu-
lation
N
reviewed
Summary of results Meta-
analysis
Recommendations future
research
Reported limitations Quality
Prevalence and co-occurrence
Monastero
[21]
Aug
2008
BPS MCI 27 Prevalence: 35 to 85%. Most common: dep,
anx and irr. Hospital-based studies reported
higher prevalence than population based
studies
- - Large cohort studies
- Using standardised MCI criteria
- Standardised behavioural
instruments
- Prognostic role of BPS in MCI
- Not exclude those with dep at
baseline
Previously proposed: - Prevalence
- Correlates
- Different MCI subtypes,
- Genetic/biological markers
Original studies
- Differences in methodology, including
setting, age and sex distribution, inclusion
and exclusion criteria and differential
sensitivity of BPS instruments
Review
- English language only
- Heterogeneity affected ability to
compare data
4
Apostolova
[22]
Dec
2006
BPS MCI 21 Prevalence: 35 to 75%. Most common BPS:
dep, apa, anx and irr. Least common: ela,
hal, dis and wan
- - Large, prospective longitudinal
studies
- Standard MCI diagnostic criteria
not excluding those with
depression
- Neuropsychiatric instruments
designed for the cognitively
impaired
Original studies
- Different sampling methods
- Exclusion of subjects with depression
- Heterogeneity of MCI diagnostic criteria
- Heterogeneity of BPS instruments
Review
- Only English literature
- Heterogeneity limits comparison
3
Seitz [23]
See 1B
Mar
2009
BPS
Dep,
Anx
Care
home
35 Prevalence BPS in dementia: 78% (median) - See Table 2 See Table 2 3
Zuidema
[24]
Aug
2005
BPS MMSE
< 24,
care
home
25 Prevalences ranged considerably, from 3 to
54% for del, 1 to 39% for hal, 8 to 74% for
dep, 7 to 69% for anx, 17 to 84% for apa, 48
to 82% for agg or agi, and 11 to 44% for
psychical agg.
- See risk factors See risk factors 2
Shub [25] NR Psy
Agg
Dem 54 Of seven cross and two long studies directly
examining correlation agg and psy, most
showed a positive association.
- - Prospectively designed studies
- Temporal relationship
Original studies
- Limited data of sufficient methodological
rigor
- Majority cross-sectional studies
3
Wragg [26] NR Dep
Psy
Dem 30 Dep and Psy occurred in 30 to 40% of AD
patients. Isolated symptoms were two to
three times as frequent as diagnosable
affective or psychotic disorders. Paranoid del
were the most common psy symptoms.
- - Specify an a priory hypothesis
- Clearly report characteristics
study sample
- Prospective and longitudinal
design
- Use standardised case definitions
- Reliable and valid BPS
instruments
- Use appropriate statistical analysis
- Clearly report conclusions
- Both theoretical and clinical
focus.
Original studies
- Methodological limitations including
small samples, misclassification bias
Review
- Relatively small number of studies
spanning several decades
- Publication bias
2
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Table 1 Characteristics of included reviews and summary of findings - older population with dementia or cognitive impairment (Continued)
Ropacki
[27]
2003 Psy Dem 55 Prevalence psy: 41% (del 36%, hal: 18%) - - Longitudinal designs
- Incidence and persistence of
psychosis
- Develop or utilise diagnostic
criteria and rating scales for
psychosis
- Take into account medication
use
- Mechanisms underlying psychosis
in AD
Original studies
- Severely cognitively impaired subjects
not included
- Potential effects of medication on
cognition
- Small standard deviations age at onset
and illness duration
- Assessing psy: diagnostic criteria
nonspecific to dementia and
inconsistencies interpreting criteria
1
Course and progression
Monastero
[21]
Aug
2008
BPS MCI 27 Prospective studies showed that BPSD,
particularly depression, may represent risk
factors for MCI or predictors for the
conversion of MCI to AD.
- See prevalence See prevalence 4
Verkaik [34] Mar
2006
Dep Dem 24 1/4 (continous) and 0/3 (categorical) high
quality studies found a significant
association between severity of AD and
prevalence of dep.
- - Longitudinal study
- Using a standardised dementia
definitions
- Assessment severity of AD
- Assessing dep with dem specific
instrument
- Control for confounders
Review
- Only English language, studies that did
not have depression or depressive
disorder as a keyword were not identified
5
Ropacki
[27]
2003 Psy Dem 55 Incidence increased progressively the first
three years, after that plateau. Duration
several months but less prominent after one
year. Associated with more rapid cognitive
decline
- See prevalence See prevalence 1
Biological
Flirski [42] ? BPS Dem 73 Behavioural genetics of BPS reviewed: genes
coding for APOE E, serotonin receptors,
serotonin transporter, COMT, MAO-A,
tryptophan hydroxylase and dopamine
receptors. A general conclusion is the
striking inconsistency of the findings,
unsurprising in the field of psychiatric
genetics.
- - Precisely define symptoms
- Fusing multidisciplinary data
Original studies
- Inconsistency of results
- Recruitment solely based on clinical
diagnosis
- Variability in study design
- BPS fluctuation, studies rely heavily on
average disease state
- Cross sectional studies
- Variety of BPS instruments
- Studying isolated symptoms or symptom
clusters
- Selection bias: ethnicity or genetic
homogeneity, choice of setting
- Insufficient number of study participants
- No correction for multiple testing
- Carrier status versus dose
- Multifactorial aetiology
0
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Table 1 Characteristics of included reviews and summary of findings - older population with dementia or cognitive impairment (Continued)
Risk factors
Zuidema
[24]
Aug
2005
BPS MMSE
< 24,
care
home
25 BPSD predicted not only by dem type or
stage, but also by the psychosocial
environment and the amount of
psychoactive medication and physical
restraints used.
- - Effects of manipulation the
physical and social environments
in nursing homes.
Original studies
- Uncertainty defining dem, its type and
severity
- Few accurately diagnosed dementia
- Different BPS instruments and definitions
2
Wragg [26] NR Dep
Psy
Dem 30 - See prevalence See prevalence 2
Ropacki
[27]
2003 Psy Dem 55 Associations: age, age at onset AD, illness
duration. Weak/inconsistent: gender,
education, family history dem or psychiatric
illness
- See prevalence See prevalence 1
Care
Gaugler
[51]
2006 BPS Dem 80 Behavioural symptoms one of most
consistent predictors of nursing home
admission in persons with dementia.
- - Interventions should consider
long-term efficacy and timing of
nursing home admission in course
of dem
- Power for subgroup analyses
- More complex models of
institutionalisation.
Review
- Research synthesis method: requires
descriptive information from samples
composed of subjects a similar age;
studies providing only correlations and
not means or standard deviations are
excluded and some assumption made
about shape of distribution.
5
Black [52] Dec
2001
BPS Dem 55 Pooled correlation coefficients for
relationship BPS and caregiver burden (0.57,
95%CI 0.52 to 0.62), caregiver psychological
stress (0.41, 0.32 to 0.49) and caregiver
depression (0.30, 0.21 to 0.39). Multivariate
data supported BPS are predictor of burden
of care, psychological distress and dep.
Limited long data. Caregiver variables may
be more important in predicting
institutionalisation than BPS.
See
summary
of results
- Concept of burden of care is too
broad and more clinically relevant
measures such as caregiver
depression are preferred.
- Cohort studies
Original studies
- Relatively few studies
- Majority clinic-based samples, few
representative
- Majority cross-sectional and correlational
- Little about which care-recipient
symptoms are most distressing or
particular risk factors for subgroups
- Concept of burden may be too broad
- Other variables are likely to be important
Review
- Publication bias
- Pooling data assumes homogeneity
(questionable)
3
Disease outcome
Lee [54] NR BPS Dem NR There was no consensus regarding the
association with dementia prognosis
- - Guideline for dementia
prognostication
- Risk score to better estimate
survival.
Original studies
- Uncertainty of etiologic diagnosis of
dementia
1
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Table 1 Characteristics of included reviews and summary of findings - older population with dementia or cognitive impairment (Continued)
Fischer [55] NR Psy Dem 6 Three of six studies showed and association
with real-world functioning
- - Longitudinal studies
- More detail about delusional
severity,
- Use cognitive and functional
measures that are better at
detecting executive impairment to
clarify the association.
Original studies
- Basic measures functional performance +
cognition
- Confounders not always taken into
account
- Considerable variation definition del
- Psychoactive medication not taken into
account
- No longitudinal studies
2
Quality of life
Banerjee
[53]
Oct
2007
BPS Dem NR Strong suggestion dep is consistently
associated with decreased health related
quality of life in dem. Magnitude of
associations is moderate and the proportion
of variance explained is low.
- - Quality of life in dementia:
determinants, in dementia
subtypes, self- versus proxy-report,
in different settings, association
with outcomes and interventions
NR 0
AD, Alzheimer’s disease; Agg, aggression; Anx, anxiety; Biol, biological associations; BPS, behavioural and psychological symptoms; Cross, Cross-sectional; Dem, Dementia; Dep, depressive symptoms; Ela, elation; Long,
longitudinal; MCI, mild cognitive impairment; Psy, psychosis; Sle, sleep problems
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Table 2 Characteristics of included reviews and summary of findings - general older population
First
author
Search
date
BPS Popu-
lation
N
reviewed
Summary of results Meta-analysis Recommendations future
research
Reported limitations Quality
Prevalence and co-occurrence
Seitz [23]
See 1A
Mar
2009
BPS
Dep
Anx
Care home 35 Prevalence dep symptoms in long
term care: 29% (14 to 82%)
- - Developing countries
- Multinational studies
- Collaboration across
centres
- Adoption of standard
survey methods
- Effective and safe
interventions
Original studies
- Small sample size
- Conducted in
developed countries
- Included relatively few
long term care facilities
- Many studies
conducted several years
ago
3
Luppa [28] May
2010
Dep Older (60+) 24 Prevalence of dep disorders ranged
from 4.5 to 37.4%. Pooled
prevalence: 17.1% (95% CI 9.7 to
26.1)
Pooled prev major dep: 7.2% (95%CI
4.4 to 10.6) Dep disorders: 17.1 (9.7
to 26.1)
- Large scale
- Population-based
- Prospective studies
- Also covering oldest age
segments
- Comorbidity, cognition
and function
- Suitable depression
diagnostics
Original studies
- Methodological
differences in study
design, sampling
structure and study
quality
5
Chen [20] Jun
1997
Dep Older (60+) 10 Prevalence dep mood: 14.8 (14.2 to
15.6%), higher in rural communities
Prev dep mood: 14.8% (14.2 to 15.6) - Similar methodology
- Culture-specific validated
instruments
- Risk factors and
understanding dep
Original studies
- Much variation
- Cultural acceptability of
instruments
4
Beekman
[29]
1996 Dep Older,
community
dwelling
(55+)
34 The reported prevalence rates vary
enormously (0.4 to 35%). Minor dep:
9.8% (8.3 to 14.3) Clinical dep
symptoms: 13.5% (2.8 to 35%)
- - Focus on those most at
risk and in adverse socio-
economic conditions
- Improving comparability of
the data
Original studies
- Methodological
differences
- Bias translating
instruments
Review
- Formal meta-analysis
was not considered
justified
3
Meeks [30] Jan
2010
Dep Older (55+) 153 Dep was generally at least two to
three times more prevalent than
major dep. Prevalence lower in
community settings (9.8%, 4.0 to
22.9) than primary care (15.1 to
35.9%) and LTC (4.0 to 30.5%).
- - Incidence
- Prevalence
- Various clinical settings,
- Diverse geographical areas
- Cultural/socioeconomic
groups
- Neurobiology
- Treatment
- Terminology of depression
- Associations with
psychopathology
Review
- Could not conduct a
meta-analysis due to
data heterogeneity
- Review did not include
data on early or mild
adulthood subthreshold
depression, limiting
extrapolation of findings
to other age groups
2
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Table 2 Characteristics of included reviews and summary of findings - general older population (Continued)
Djernes
[31]
Sep
2004
Dep Older (65+) 122 Prevalence clinical relevant
depressive symptoms: 7.2 to 49%
- - Target risk factors,
improvement of prevention
and treatment of chronic
somatic and mental
illnesses, adequate social
support, prevention social
isolation
- Education and information
dep in elderly
- Comparability of
methodology
- Focus on nursing home
residence
Original studies
- Methodological
differences
- Rates of participation;
depressed elderly may
be particularly prone to
refuse research
invitations
- Subjective variations in
the assessment of the
presence or absence of a
diagnostic criterion
- Differences between
instruments
2
Alwahhabi
[32]
2001 Anx Older (55+) 119 - See disease outcome See disease outcome 1
Course and progression
Huang [35] Aug
2007
Dep Older (55+) 17 Non-dementia cognitive impairment
vs without: incidence dep: OR = 1.5,
95% CI 0.9 to 2.5 prevalence dep: RR
= 1.1, 95% CI 0.6 to 2.0. Dem vs. no
dem: incidence OR = 1.8, 85% CI 1.2
to 2.9, prevalence RR = 3.9, 95% CI
1.9 to 8.0
See summary of results - Risk for cognitive
impairment for depression
Review
- No conclusion if dep
was risk factor for dem
- No hand-search of
journals and no attempt
to identify unpublished
studies. English language
only
- Heterogeneity among
included studies
- Confounding
comorbidity other
psychiatric disorders
- Data only gathered
until august 2007
- Only four longitudinal
studies included
5
Meeks [30] Jan
2010
Dep Older (55+) 153 8 to 10% of subthreshold dep
developed major dep per year.
Median remission rate to non-dep
status 27% after > 1 year.
- - Longitudinal course See prevalence 2
Jorm
[33,36,37]
End
2000
Dep Dem/Older 11, 15, 2 1991: history of dep (late onset
cases) associated with AD (late
onset). 2000: Dep increased risk of
dem in case control, 95% CI 1.2 to
3.5 and prospective studies, 95% CI
1.1 to 3.2.; 2001: Update 2000: case
control studies: RR = 2.0, 95% CI 1.2
to 3.5, prospective studies 1.9, 95%
CI 1.1 to 3.2
Too many results 1991:
- Prospective studies
- History of psychiatric
disorders other than dep
and psychiatric treatments
2000/2001:
- Large sample size
- Mechanisms association
dep and dem
Review
1991
- The pooled analyses
cover only a small
number of exposures
from the domain of
psychiatric history
0
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Table 2 Characteristics of included reviews and summary of findings - general older population (Continued)
Ohayon
[38]
2003 Sle Adult
("healthy or
normal”)
65 Total sleep time, sleep efficiency,
percentage of slow-wave sleep,
percentage of REM sleep and REM
latency all significantly decreased
with age. Sleep latency, waking after
sleep, waking after sleep duration
and the percentage of stage 1 and
2 sleep increase with age, but only
sleep efficiency continued to
significantly decrease after 60 yr.
Age - sleep: TST: r = -0.76 P <
0.0001 Sleep efficiency: r = -0.82, %
SWS: r = -0.56% REM: r = 0.16 Sleep
latency: r = 0.16% stage 1 sleep: r =
0.16% stage 2 sleep: r = 0.34 WASO:
r = 0.75 All P < 0.0001
- Strict screening methods
- Effect of race
- Take into account subjects’
habitual sleep schedules as
well as whether PSG
recording occurs on
weekday or weekend night
Original studies
- No information given in
relation with the
presence or absence of
sex differences, no
information about race
composition
- Several studies did not
include middle-aged
subjects
Review
- Limited to peer-
reviewed studies
3
Floyd [39] 2002 Sle Adult
("healthy or
normal”)
244 Age and REM%: essentially linear,
decreasing 0.6% per decade but
ceased during mid-70s followed by
small increase 75 to 85
Age - REM%: r = -0.17 - REM sleep in women
- More data in old-old
population
Review
- Studies did not screen
for psychoactive
substance use, dep and
sleep apnea, few studies
of women
- Univariate approach
- Publication bias
2
Floyd [40] 1996 Sle Adult 41 Night-time sleep amount and the
ability to initiate sleep decreased
with age. Larger age-related
changes when sleep variables were
measured by polysomnography
rather than self-report.
Age - sleep, effect size: Sleep
latency: 0.19 (0.14 to 0.24) WASO
frequency: 0.38 (0.34 to 0.42) WASO
duration: 0.74 (0.71 to -0.77) Night
time sleep amount: -0.33 (-0.37 to
-0.28)
- Controlling for health
moderators (carefully
assessed for levels of
depression, sleep apnea and
use of psychoactive
substances)
- Study women
Original studies
- Inclusion or exclusion
of certain covariates may
have influenced which
predictors emerged as
significant
- Very few of the studies
examined the effects of
collinearity, moderation
or mediation among
critical predictor variables
- Range of quality scores
Review
- Heterogeneity made
the estimation of pooled
effects impractical
1
Biological
Huang [43] Aug
2007
Dep Older (55+) 28 Significant OR and RR for increased
dep in old age: stroke, loss of
hearing, loss of vision, cardiac
disease or chronic lung disease had
a. Significant OR but un-significant
RR: arthritis, hypertension and
diabetes. Both OR and RR not
significant: gastro-intestinal disease
Too many results Review
- Not hand-search
journals, not identify
unpublished studies,
three databases, only
English language
- Risk factors dep might
be differently related to
the onset, chronicity and
recurrence but not
differentiated
- Recent life event not
taken into account
- Heterogeneity in results
5
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Table 2 Characteristics of included reviews and summary of findings - general older population (Continued)
Huang [44] Aug
2007
Dep Older (55+) 31 Chronic disease - dep: RR = 1.5, 95%
CI 1.2 to 2.0. poor SRH - dep: RR =
2.4, 95% CI 1.9 to 3.0.
Chronic disease - dep: RR = 1.5 (1.2
to 2.0) SRH - dep: RR = 2.4 (1.9 to
3.0)
Review
- Not hand-search
journals, no attempt to
identify unpublished
studies, three databases,
only English
- Heterogeneity in results
5
Almeida
[45]
Dep Older (70+) 17 High tHcy increased risk of dep: OR
= 1.7, 95% CI 1.4 to 2..1 TT vs. CC
carriers: OR = 1.2, 95% CI 1.0 to 1.5
High tHcy - dep: OR = 1.7 (1.4 to
2.1)
MTHFR C677T - dep: TT vs CC: OR =
1.2 (1.0 to 1.5) CT vs CC: OR = 1.1
(0.9 to 1.2)
- Sufficiently powered
randomised trials
Original studies
- Small sample size (trials)
- Reverse causality
(observation studies)
- Inconsistent definition
phenotype,
misclassification bias
(genetic studies)
- Lack of reliable
information on ethnicity
Review
- Meta-analysis lacked
power
4
Stetler [46] May
2009
Dep Adult 414 Dep vs no dep: Cortisol d = 0.6
(95% CI 0.5 to 0.7)
Adrenocorticotropic-releasing
hormone d = 0.28 (95% CI 0.2 to
0.4) Corticotropin-releasing hormone
d = 0.02 (95% CI -0.5 to 0.5)
Too many results - Bioinformatic technologies
- Larger sample size
- Longitudinal
Original studies
- High degree of
heterogeneity
- Publication bias
possible
- Based on cross-
sectional studies
- Arbitrary criteria for
minimal methodological
quality
- Most of the included
studies were
underpowered
3
Kuo [47] Sep
2004
Dep Adult 19 High concentrations C-reactive
protein predictive of cognitive
decline and dem. Relations to dep
cross and not consistent.
- - Prospective study c-
reactive protein-dep
- Intervention studies to
lower c-reactive protein and
improved outcomes
NR 3
Kuo [41] Mar
2004
Dep Older (55+) NR Growing evidence of association
hyper-homocysteinemia and
cognitive impairment, dem and dep.
Proposed mechanisms include
angiotoxicity, neurotoxicity, and
inhibition of collagen cross-linking
- - Role of homocysteine in
prevention
- Prospective studies
association with dep
- Adequate adjustment for
possible confounders
NR 3
Camus [48] Jun
2003
Dep Older NR Potential ways association dep -
vascular disease: 1 direct influence
vascular disease, 2 direct influence
dep, 3 common causes
- - Pathophysiological and
genetic background of
vascular depression
NR 1
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Table 2 Characteristics of included reviews and summary of findings - general older population (Continued)
Vink [49] Dec
2005
Anx
Dep
Older (50+) 80 Risk factors anx and dep showed
many similarities but some
differences were found. Biological
factors may be more important in
predicting dep, and a differential
effect of social factors on dep and
anx was found.
- - Intervention (whether
manipulation of risk factors
reduces the onset of anx/
dep)
- Clearer understanding of
etiological factors
differentiating anx and dep
Review
- Heterogeneity between
studies, no meta-analysis
- Only main effects of
risk factors on anx and
dep
- Heterogeneity limits
comparison across
studies
- Risk factors that have
not yet been studied
- No distinction made
between different anx
disorders
1
Risk factors
Chen [20] Jun
1997
Dep Older (60+) 10 The patterns of risk factors were
similar to those in western countries
See prevalence See prevalence See prevalence 4
Meeks [30] Jan
2010
Dep Older (55+) 153 Risk factors: female, medical burden,
disability and low social support;
neurological illnesses (Parkinson’s
disease, stroke, AD)
- - While some risk factors are
well established, others
remain to be identified.
See prevalence 2
Djernes
[31]
Sep
2004
Dep Older (65+) 122 Risk factors: female, somatic illness,
cognitive and functional
impairment, lack of social contacts,
history of dep
- See prevalence See prevalence 2
Cole [50] 2001 Dep Older (50+) 20 Risk factors, Qualitative: disability,
new medical illness, poor health
status, prior depression, poor self-
perceived health, and bereavement.
Quantitative: bereavement, sleep
disturbance, disability, prior
depression, female gender
13 risk factors investigated. OR
ranged from 1.0 to 3.3, significant
risk factors: bereavement, sleep
disturbance, disability, prior dep,
female gender
- Intervention Original studies
- Follow-up incomplete
in most studies
- Differences in the
length of follow-up
- Differences in
definitions risk factors
and adjustment
- Many potential risk
factors not studied
adequately
- Cumulative effect of
multiple risk factors not
studied
- Heterogeneity in the
results
Review
- Search by one author
only
- Only English or French
literature
- Did not assess
publication bias
- Abstracted by one
author
2
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Table 2 Characteristics of included reviews and summary of findings - general older population (Continued)
Vink [49] Dec
2005
Anx,
Dep
Older (50+) 80 Risk factors both anx and dep:
personality, coping strategies,
previous psychopathology, social
network, stressful life events, female.
Dep: smaller network size, being
unmarried.
- See biological See biological 1
Disease outcome
Meeks [30] Jan
2010
Dep Older (55+) 153 Consequences: disability, greater
healthcare utilisation, increase
suicide ideation
- - More sophisticated health
economic studies
See prevalence 2
Alwahhabi
[32]
2001 Anx Older (55+) 119 Limitations: understanding
expression anx, variable definitions
elderly, diagnostic instruments. Anx
in elderly potential for negative
consequences independent of
comorbidity major dep.
- - Definition of elderly
- Symptom definition and
diagnostic instruments
- Clinical trials
Original studies
- No common definition
of the lower limit of
geriatric age
1
AD, Alzheimer’s disease; Agg, aggression; Anx, anxiety; BPS, behavioural and psychological symptoms; Cross, Cross-sectional; Dem, Dementia; Dep, depressive symptoms; Ela, elation; Long, longitudinal; MCI, mild
cognitive impairment; Prev, prevalence; Psy, psychosis; Sle, sleep problems; SRH, self-rated health
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Table 3 Methodological quality of systematic reviews assessed with the AMSTAR measurement tool
Author 1 A priori
design
2
Duplicate
3
Search
4
Publication
status
5 List of
studies
6
Characteristics
studies
7 Scientific
quality reported
8
Conclusions
9 Combination
methods
10
Publication
bias
11 Conflict of
interest
Score Quality
Almeida
[45]
Can’t
answer
Can’t
answer
No No No Yes Yes No Yes Yes No 4 Low
Alwahhabi
[32]
Can’t
answer
Can’t
answer
No No No No Yes No Not applicable No No 1 Low
Apostolova
[22]
Can’t
answer
Can’t
answer
No No No Yes Yes Yes Not applicable No No 3 Low
Banerjee
[53]
Can’t
answer
Can’t
answer
Can’t
answer
No No No No No Not applicable No No 0 Low
Beekman
[29]
Can’t
answer
Can’t
answer
No Can’t answer No Yes Yes Yes Not applicable No No 3 Low
Black [52] Can’t
answer
Can’t
answer
Can’t
answer
No No Yes Yes Yes No No No 3 Low
Camus [48] No Yes No No No No No No Not applicable No No 1 Low
Chen [20] No Can’t
answer
No Yes No I Yes No Yes Yes No No 4 Low
Cole [50] Can’t
answer
No Can’t
answer
No No Yes Yes No No No No 2 Low
Djernes [31] Can’t
answer
Can’t
answer
Can’t
answer
Can’t answer No Yes Yes No Not applicable No No 2 Low
Fischer [55] Can’t
answer
Can’t
answer
Can’t
answer
No No Yes No Yes Not applicable No No 2 Low
Flirski [42] Can’t
answer
Can’t
answer
No Can’t answer No No No No Not applicable No No 0 Low
Floyd [40] Can’t
answer
Can’t
answer
Can’t
answer
No No No No No Yes No No 1 Low
Floyd [39] Can’t
answer
Yes Can’t
answer
Yes No No No No No No No 2 Low
Gaugler
[51]
Can’t
answer
Yes Can’t
answer
Yes No Yes Yes Yes Not applicable No No 5 Moderate
Huang [35] Can’t
answer
Yes Can’t
answer
Can’t answer No Yes Yes No Yes Yes No 5 Moderate
Huang [43] Can’t
answer
Yes Can’t
answer
Can’t answer No Yes Yes No Yes Yes No 5 Moderate
Huang [44] Can’t
answer
Yes Can’t
answer
No No Yes Yes No Yes Yes No 5 Moderate
Jorm
[33,36,37]
No Can’t
answer
Can’t
answer
Can’t answer No No No No No No No 0 Low
Kuo [47] Can’t
answer
Yes No No No Yes No Yes Not applicable No No 3 Low
Kuo [41] Can’t
answer
Can’t
answer
No No No I Yes No Yes Not applicable No No 3 Low
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Table 3 Methodological quality of systematic reviews assessed with the AMSTAR measurement tool (Continued)
Lee [54] Can’t
answer
Can’t
answer
No No No Yes No No Not applicable No No 1 Low
Luppa [28] Can’t
answer
No Can’t
answer
No No Yes Yes Yes Yes Yes No 5 Moderate
Meeks [30] Can’t
answer
Can’t
answer
No No No Yes No Yes Not applicable No No 2 Low
Monastero
[21]
Can’t
answer
Yes No No No Yes Yes Yes Not applicable No No 4 Low
Ohayon
[38]
Can’t
answer
Can’t
answer
Can’t
answer
No No Yes Yes Yes No No No 3 Low
Ropacki
[27]
Can’t
answer
Can’t
answer
Can’t
answer
No No Yes No No Not applicable No No 1 Low
Seitz [23] Can’t
answer
Yes Can’t
answer
Can’t answer No Yes No Yes Not applicable No No 3 Low
Shub [25] Can’t
answer
Can’t
answer
No No No Yes Yes Yes Not applicable No No 3 Moderate
Stetler [46] Can’t
answer
No No No No Yes No Yes No No No 3 Low
Verkaik [34] Yes Yes Can’t
answer
No No Yes Yes Yes Not applicable No No 5 Moderate
Vink [49] Can’t
answer
Can’t
answer
Can’t
answer
No No Yes No No Not applicable No No 1 Low
Wragg [26] Can’t
answer
Can’t
answer
No No No Yes No Yes Not applicable No No 2 Low
Zuidema
[24]
Can’t
answer
Can’t
answer
No Can’t answer No Yes No No Not applicable No No 2 Low
Response options: yes, no, can’t answer, not applicable.
Full questions: A priori design: Was an “a priori” design provided? Duplicate: Was there duplicate study selection and data extraction? Search: Was a comprehensive literature search performed? Publication status:
Was the status of publication (that is, grey literature) used as an inclusion criterion? List of studies: Was a list of studies (included and excluded) provided? Characteristics studies: Were the characteristics of the
included studies provided? Scientific quality reported: Was the scientific quality of the included studies assessed and documented? Conclusion: Was the scientific quality of the included studies used appropriately in
formulating conclusions? Combination methods: Were the methods used to combine the findings of studies appropriate? Publication bias: Was the likelihood of publication bias assessed? Conflict of interest: Was the
conflict of interest stated? Score: The maximum AMSTAR score a review can receive is 11 (11 for meta-analyses and 10 for systematic reviews) Quality: Scores of 0 to 4 indicated low quality, 5 to 8 moderate quality,
and 9 to 11 high quality.
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data. Recommendations include the use of standardised
BPS instruments and the study of various populations.
Longitudinal course and association with cognitive decline
Monastero et al. reported that prospective studies
showed that BPS, particularly depression, might repre-
sent risk factors for MCI or predictors of MCI conver-
sion to dementia [21]. A review of moderate scientific
quality failed to find evidence of an association between
depressive symptoms and severity of dementia [34]. A
review on psychotic symptoms suggested that these
symptoms increase with the development of dementia
but plateau after three years [59].
Few reviews on BPS course have been conducted in the
older population. Huang et al. reported that compared to
individuals without cognitive impairment, incidence and
prevalence of depression was higher in those with cogni-
tive impairment or dementia. Meeks et al. found that
depression was relatively stable in the older population,
with a median remission of 27% after more than one year
[30]. Three reviews by Jorm et al. concluded that history
of depression in cognitively normal persons was associated
with increased risk of dementia [33,36,37,60]. Sleep pro-
blems including sleep latency and waking after sleep were
common with increasing age, but only sleep efficiency
continued to significantly decrease after age 60 [38-40].
The reviews identified a need for more longitudinal
studies using standardised measures of cognitive func-
tion and BPS and appropriate adjustment for confound-
ing factors.
Biopsychosocial associations
Biological factors A systematic review shows inconsis-
tent results for genetic associations, including genes
coding for APOE E, serotonin receptors and transporter,
COMT, MAO-A, tryptophan hydroxylase and dopamine
receptors with BPS in individuals with dementia [42].
No other reviews were found.
In the general older population, most reviews of biolo-
gical correlates of BPS focus on depression. An associa-
tion between high levels of homocysteine and depression
and dementia has been reported [41,45]. Stetler et al.
suggest an association between depression and cortisol
and other hormones [46]. In addition, cerebral athero-
sclerotic changes may result in cognitive impairment and
depression, possibly mediated by C-reactive protein but
results were not consistent [47]. The association between
vascular factors and depression was further studied and
discussed in a review by Camus et al. [48].
Recommendations for future research include pro-
spective studies with large sample sizes further investi-
gating the association with biological factors.
Risk factors In nursing home patients with cognitive
impairment, BPS were associated with the psychosocial
environment, in addition to dementia type and stage
and medication use [24]. In dementia patients, psychosis
has been associated with age, illness duration and func-
tional impairment, whereas results are weak or inconsis-
tent for sociodemographic variables [27].
In two moderate quality reviews of the older popula-
tion by Huang et al., depression was reported to be
common in those with poor self-rated health, disability
and chronic disease, including stroke, sensory impair-
ment, cardiac disease or chronic lung disease [43,44].
Depression is more common in women, and has been
associated with many risk factors, including other dis-
eases, low social support, cognitive impairment, disabil-
ity, prior depression and bereavement [20,29-31,49,50].
Vink et al. report that health factors were less clearly
related to anxiety than to depression [49]. Psychosocial
associations of other BPS have not been reviewed.
More research is recommended on risk factors for
depression and randomised controlled trials to investigate
if manipulation of risk factors reduces the onset of BPS.
Outcomes and care
Some evidence suggests that BPS predicts nursing home
placement in those with dementia [51]. Burden of care,
caregiver’s general health and caregiver depression scores
have been associated with BPS, but perhaps caregiver’s
perception of the BPS and caregiver’s social and psycho-
logical resources prior to institutionalisation are more
important factors [52]. Lee et al. concluded that there
was no consensus regarding the association between BPS
and increased mortality in individuals with dementia
[54]. Studies of associations between delusions in demen-
tia and functional outcome had inconsistent results [55].
Finally, depression has been associated with decreased
health related quality of life in dementia, although the
size of the association was moderate [53].
Depression in the general older population has been
associated with increased health care utilisation and
expenditure [30]. In addition, anxiety in the elderly has
been reported to have negative consequences indepen-
dently of depression [32].
The reviews recommend more research with better
measurements of determinants and outcomes and more
sophisticated techniques to analyse the association with
disease outcomes.
Summary: limitations and recommendations
Overall, the reviews reported several limitations of the
original studies, including heterogeneity in methodology,
insufficient adjustment for confounders, heterogeneity in
BPS instruments and definitions, small sample size and
that most studies were cross-sectional (Figure 2). This
led to recommendations for prospective longitudinal stu-
dies, with a large sample size and using standardised BPS
instruments and definitions. The following topics for
future research were most often recommended, including
intervention and treatment, mechanisms and underlying
van der Linde et al. Alzheimer’s Research & Therapy 2012, 4:28
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causes of BPS and the prevalence, incidence and persis-
tence of BPS. Many reviews reported that comparison of
results was limited due to heterogeneity of the included
studies.
Gaps
Figure 3 gives an overview of the number of reviews
that studied each BPS by the topic of the review. Most
of the included reviews focused on individuals with
dementia or cognitive impairment studied depression or
psychotic symptoms, and they most often studied the
prevalence of symptoms. Of the reviews of older popula-
tions, almost all studied depressive symptoms and some
studied sleep problems or anxiety, whereas the other
BPS were not investigated.
Discussion
Summary of findings
• Prevalence. BPS occur in non-demented, cogni-
tively impaired and demented populations, but there
are large variations in reported prevalence estimates.
• Biological associations. Biological factors asso-
ciated with BPS include health status, homocysteine
levels and vascular disease.
• Risk factors. Associations have been found with psy-
chosocial environment and dementia severity. Results
are inconsistent, especially for socio-demographic fac-
tors, and differ between symptoms.
• Outcomes and care. BPS have been associated with
increased burden of care, decreased caregiver’s general
health and increased caregiver depression scores, but
Recommendations made by included reviews in discussion section 
Methods recommended for future studies  Topics recommended for future studies 
Prospective longitudinal studies,
n = 13
Large sample size, n = 8
Standardised instruments, n = 7
Different populations, n = 3
Include oldest old, n = 3
Improved comparability, n = 3
Interventions and
treatment, n = 8
Mechanisms, biological
factors and underlying
causes BPS, n = 5
Prevalence, incidence and
persistence, n = 3
Limitations reported by included reviews in discussion section 
Limitations of original studies     Limitations of reviews as reported by the  
as reported by the included reviews   reviews      
Heterogeneity in methodology,
n = 9
Confounder issues, n = 7
Heterogeneity in BPS
instruments and definitions,
n = 6
Small sample size, n = 5
Majority cross-sectional and
correlational, n = 5
Selection bias, n = 4
Diagnosing of dementia and
cognition, n = 3
Comparison or meta-
analysis limited due to
heterogeneity studies,
n = 11
Limitations search, n = 7
Confounder issues, n = 4
Publication bias, n = 3
Figure 2 Overview of the recommendations and limitations reported by the included reviews. In total, 36 reviews were included in the
review of reviews. Only recommendations and limitations reported by three or more reviews are included in the figures. Reviews that make
multiple recommendations or limitations may be included more than once.
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these conclusions come from a limited number of stu-
dies. Findings in relation to BPS and institutionalisa-
tion, quality of life and disease outcome are generally
inconsistent.
Limitations of reviews
Over 97,000 articles have been published on BPS in
recent years (up to July 2011). However, in total, only
36 systematic reviews were identified, published from
Reviews that reported on demented or cognitively impaired populations 
All BPS Dep Psy Irr Anx Apa Sle Wan Ela Agi
Prevalence
Risk factors
Outcomes and 
care
Course
Biological
Reviews that reported on older populations 
All BPS Dep Psy Irr Anx Apa Sle Wan Ela Agi
Prevalence
Risk factors
Outcomes and 
care
Course
Biological
3 or more reviews 1 or 2 reviews No reviews
Figure 3 Number of reviews that reported on each symptom by the topic of the review. Agg, aggression; Agi, agitation; Anx, anxiety; BPS,
behavioural and psychological symptoms; Dep, depressive symptoms; Ela, elation; Psy, psychosis; Sle, sleep problems; Wan, wandering; In total 36
reviews were included in the review of reviews. Reviews that report on multiple topics or more than one BPS are included more than once.
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1989 to 2011, covering 6 to 244 papers, with only 10
reviews, including a meta-analysis. These covered a wide
area of research and included studies with large differ-
ences in population characteristics, recruitment and
definition of BPS. Depressive symptoms were most
widely reviewed. Other symptoms, such as apathy, irrit-
ability, wandering and elation, are typically ignored,
especially in studies of the older population. Aggression,
psychosis and wandering have been identified as the
BPS that are most difficult to cope with by caregivers
[61]. Not all areas of BPS research have yet been ade-
quately reviewed. For example, no review has yet
appeared on the neuropathology underpinning BPS,
although there are several recent studies on this subject
and many possible biological mechanisms may underlie
BPS, such as Alzheimer’s disease pathology, lower neu-
ronal counts, neurotransmitter changes, genetic risk fac-
tors and abnormal neuroendocrinology [62-64]. A high
quality systematic review of the biological underpinnings
of BPS would give direction to further research, particu-
larly with regard to treatment development.
The quality of the included reviews as measured with
the AMSTAR tool was generally low. All except one did
not report if the research question and inclusion criteria
were established before the conduct of the review, or
they did not provide a research question and/or inclusion
criteria. Many reviews did not have two independent
researchers who selected the studies and extracted the
data, or did not report this. None of the reviews reported
the potential conflict of interest of the included studies.
Furthermore, the inclusion of grey literature and if the
search was supplemented by consulting current contents,
reviews, textbooks, specialised registers or experts were
rarely reported.
Better and more systematic reporting would make it
easier to compare the characteristics, results and strengths
and limitations of reviews, and the use of reporting check-
lists, such as PRISMA, is recommended [65]. More details
on the populations covered by the review and the charac-
teristics of included studies would be particularly helpful.
Recommendations for future research made by the
reviews were variable, with many recommendations
made only by one or two reviews. Only more general
recommendations were made by several reviews. This
has been previously reported by Clark et al., who exam-
ined 2,535 Cochrane reviews and found that the charac-
terisation of the needs for future research was less than
explicit [66]. In addition, it has been previously found
that reviews tend to be too optimistic when drawing con-
clusions from their results [67,68]. It has been recom-
mended that research gaps should be identified more
systematically, rating the reasons of research gaps in
terms of population, intervention, comparison, outcome
and setting (PICOS), including insufficient information,
biased information, inconsistency or not the right infor-
mation [69], although this tool has been designed for
reviews of intervention studies and may not be suitable
for reviews of observational studies.
Limitations of original studies
The reviews have included individual research studies with
a large degree of heterogeneity in study design (for exam-
ple, definition and measurement of BSP, level of cognitive
impairment, population characteristics and recruitment of
participants), making cross study comparisons difficult.
Many different instruments are used to measure BPS,
including the Neuropsychiatric Inventory (NPI) [70],
CERAD-BRSD [71] and the Behavioral Pathology in Alz-
heimer’s Disease scale (BEHAVE-AD) [72]. Symptom-spe-
cific instruments are also used, including the Geriatric
Depression Scale (GDS) for depressive symptoms [73].
Some instruments use self-ratings (for example, GDS),
while others are based on a caregiver interview (for exam-
ple, NPI). Across instruments there is no consistency in
the definition and severity of the symptoms.
Some studies focused on the general older population,
while others selected only those with dementia or MCI.
Even within impaired groups large differences exist in
the measurement of cognitive function. Some study
populations were divided by cognitive status (for exam-
ple, normal, mild or other cognitive impairment and
dementia) using diagnostic criteria applied indepen-
dently of BPS. It may be that the phenotypes of BPS (for
example, the causes of depression or agitation) have a
different basis at different stages of cognitive impair-
ment and, therefore, studies using different groups will
have discrepant findings. Other features, such as the age
and gender of participants, and the setting where they
were recruited, also vary. If samples are not representa-
tive of the population (either that of older people in the
community or people with dementia) conclusions may
be difficult to generalise.
Limitations of our review of review
There is no Mesh or Emtree search term for BPS, so
search terms for individual symptoms and text searches
had to be combined. As many different terms are used
to describe BPS, it is possible that we may have missed
relevant reviews, though we have checked all reference
lists of relevant papers. One author undertook data
selection and extraction.
Many different definitions of BPS have been used in
the literature. Here we used symptom definitions as
used by the most commonly used instruments to mea-
sure BPS, including the NPI. However, symptom defini-
tions may overlap and there was heterogeneity in
symptom definitions that were used by the reviews.
Depression is especially problematic. All of the reviews
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included here that studied depression included studies
investigating major depression as well as studies investi-
gating depressive symptoms. In the original studies,
decisions about depression can be made at recruitment,
when applying the inclusion and exclusion criteria or
during measurement at baseline and follow-up. In some
studies, only people with or without depressive symp-
toms or major depression are recruited, or participants
with major depression can be excluded from the study
at the participant selection stage. At the data collection
stage, the definition of depression can include both
major depression and minor depression using a cut-off
score (for example, a CES-D score higher than 16); it
can include both depressive symptoms and major
depression separately (for example, DSM definitions for
major and minor depression or CES-D scores 16 to 20
and CES-D higher than 20), or either depressive symp-
toms only (for example, using the Neuropsychiatric
Inventory to measure depressive symptoms in the con-
text of BPSD) or major depression only (for example,
DSM definition for major depression).
By reviewing reviews and not the original studies, it is
likely that noise has been introduced. Furthermore, with
the diverse and generally qualitative outcomes of the
majority of reviews, we were unable to combine results
quantitatively and, therefore, a meta-meta-analysis was
not possible.
Recommendations for future research
Recommendations for future reviews on BPS:
• More reviews on BPS are needed, for example, on
neuropathological associations
• Improve the quality of reporting of reviews
• Choose reviews that include all BPS not just symp-
toms of depression/psychosis
• Clearer reporting, using a checklist tool, for exam-
ple, PRISMA
• Clearer and more specific recommendations for
future research, for example, PICOS if applicable
Recommendations for original research on BPS:
• Prospective longitudinal studies
• Large sample size
• Standardised instruments for BPS
• Wide age range, including oldest old
• Improved comparability of results; report study
characteristics clearly
Conclusions
No clear conclusions could be made on the prevalence,
biology, risk factors and outcomes of BPS. However, by
pulling together this wide variety of research, we have
been able to give an overview of the recommendations,
limitations and gaps of current research in BPS that
may inform future research. More high quality reviews
including all BPS, not just depressive symptoms, are
needed. Future original research should include longitu-
dinal studies with larger sample sizes to further assess
the complex relations between BPS, cognitive function
and psychological, social and biological factors. One of
the main questions raised by the reviews is how best to
define and measure BPS within and across populations
(that is, different levels of cognitive function, population
vs. clinical based). A wider use of the most frequently
cited instruments to measure BPS, such as the NPI,
would improve comparability. Studies should report
clearly the characteristics of their population, the inclu-
sion and exclusion criteria that were used and how they
defined BPS, particularly depression. A better under-
standing of BPS, including their definition, evaluation,
underlying mechanisms, risk factors, prevalence and
progression will have important implications for preven-
tion and treatment. This has the potential to signifi-
cantly improve quality of life in people with dementia
and their carers as well has having other positive
impacts, for example, on economics, institutionalisation
and worsening of both cognitive and non-cognitive
symptoms.
Additional material
Additional file 1: Search terms (Embase and Medline, 29 March
2012). An overview of the search terms that were used.
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